Public shortcut

Why gene sequencing company Berry reverse-merging to gain China listing

Berry Genomics Co. Ltd. hopes to cut its path to a public listing in half by opting for a reverse merger rather than an IPO.

According to a Dec. 4 regulatory filing, Berry plans to reverse-merge with auto parts company

Read the full 393 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers